Navigation Links
Entinostat Demonstrates Activity in Hodgkin's Lymphoma
Date:12/11/2011

WALTHAM, Mass., Dec. 11, 2011 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. announced today that data from ENGAGE 501, a multicenter, phase 2 study, demonstrated entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, showed activity as a single agent in patients with relapsed or refractory Hodgkin's lymphoma (HL).  This data is being presented today, December 11, from 6:00 to 8:00 PM PT at the American Society of Hematology Annual Meeting and Exposition in San Diego.  

"Showing activity in this hard-to-treat patient population, demonstrates potential for entinostat to treat Hodgkin's lymphoma," said Anas Younes, MD, professor, department of lymphoma/myeloma, division of cancer medicine, The University of Texas MD Anderson Cancer Center. "These results are consistent with what has been seen with other HDAC inhibitors with a lower rate of toxicity warranting further study of entinostat particularly in combination strategies and at an earlier stage of disease."

Highlights of the data include:

  • Antitumor activity observed in HL patients progressing after SCT with bulky disease in about a third of patients within two cycles of therapy
  • Progression-free survival (PFS) showed durable responses in bulky disease patients
  • Overall survival (OS) was an exploratory endpoint with data that is still maturing
  • Entinostat was well tolerated and the safety profile is consistent with previous studies allowing for future combination treatments.

"We are pleased to see that the results of ENGAGE 501 provide evidence of single-agent activity for entinostat in Hodgkin's lymphoma," said Joanna Horobin, MD, president and chief executive officer of Syndax.  "Given this data combined with the recently reported '/>"/>

SOURCE Syndax Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Syndax Pharmaceuticals Announces Issuance of EU Patent for Entinostat
2. SAFC Hitech(TM) Successfully Demonstrates Device-Quality GST Precursors For Phase Change Memory Applications
3. SuperGens MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy
4. EntreMeds ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
5. Vaxart Demonstrates Efficacy of Oral Avian Flu Vaccine in Preclinical Studies
6. Study From the University of Texas M.D. Anderson Cancer Center Demonstrates That AHCC(R) is Safe in Combination With Most Chemotherapeutic Agents
7. RVX-208 Data Demonstrates Increase in Functional HDL Particles
8. Antheras Varespladib Demonstrates Significant Anti-Inflammatory Effect and LDL Reduction in Patients With Coronary Heart Disease
9. Human clinical study demonstrates superior Neptune Krill Oil NKO(R) pharmacokinetic profile
10. Sparta Systems Demonstrates Global Enterprise Quality Management Leadership at TrackWise(R) Connection User Conferences
11. Epilepsia Study Demonstrates New Add-on Antiepileptic Drug Vimpat(R) (lacosamide) Significantly Reduces Partial-Onset Seizures in Adults With Epilepsy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , September 18, 2014 /PRNewswire/ ... Markets ( http://www.researchandmarkets.com/research/czvg3s/biocompatible ) has announced ... Materials - Global Strategic Business Report" ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ,This report analyzes the ... US$ Million by the following Product ...
(Date:9/18/2014)... -- Research and Markets has announced the ... Industry Report, 2014-2017" report to their offering. ... can differentiate into specialized cells and can divide (through ... can be applied to treatment of cardiovascular diseases, leukemia ... damage or lesion of liver, kidney and other parenchymal ...
(Date:9/18/2014)... , Sept. 18, 2014 Research ... "Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, ... report to their offering. The global ... CAGR of 22.7% from 2014 to 2019. Factors such ... growing adoption of companion diagnostics by the pharmaceutical industry, ...
(Date:9/18/2014)... , Sept. 18, 2014  MEI Pharma, Inc. (Nasdaq: ... clinical development of novel therapies for cancer, announced today that ... Officer, will present at BioCentury,s NewsMakers in the Biotech ... a.m. Eastern time from the Millennium Broadway Hotel & Conference ... webcast of the presentation can be accessed at www.meipharma.com ...
Breaking Biology Technology:Biocompatible Materials - Global Strategic Business Report 2014 2Biocompatible Materials - Global Strategic Business Report 2014 3Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 2Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 3MEI Pharma To Present At BioCentury's NewsMakers Conference 2MEI Pharma To Present At BioCentury's NewsMakers Conference 3
... consulting firm ,based in Draper, UT, named Epic Systems ... Report Card. The study, which included 200 vendors, was ... and clinicians representing over 4,000 healthcare facilities. , ,KLAS ... information technology (HIT) vendors and releases its Top 20 ...
... game makers , ,Eau Claire, WI-- Silicon ... Graphics of Wilsonville, Ore., to offer improved custom ... spectrum. , ,The business collaboration is meant to speed ... additional manufacturing operations due to undetected errors in very ...
... intranet infrastructure helped Cisco Systems - the ... explosive growth in the late '80s ad early '90s. ... has come from careful expansion of the company's product ... Marquette University Business Leaders Forum Breakfast. , ...
Cached Biology Technology:Silicon Logic Teams Up to Save Money 2Cisco Chairman Praises University Research 2Cisco Chairman Praises University Research 3
(Date:9/18/2014)... be cheerful, happy-go-lucky characters, so you might expect that ... , In fact some dogs are distinctly more pessimistic ... , "This research is exciting because it measures ... non-invasively. It offers researchers and dog owners an insight ... said Dr Melissa Starling, from the Faculty of Veterinary ...
(Date:9/18/2014)... it that when people are too stressed they are ... the Brain Mind Institute (BMI) at EPFL have just ... between chronic stress and the loss of social skills ... attacks a synaptic regulatory molecule in the brain. This ... Communications . , Carmen Sandi,s team went to ...
(Date:9/17/2014)... health care to reproductive technologies, the justice and ... of people to identify key issues, articulate their ... find the most defensible ways forward. But what ... societal conversations?, The Hastings Center and the Presidential ... teamed up to publish a series of essays ...
Breaking Biology News(10 mins):Dogs can be pessimists too 2Dogs can be pessimists too 3How stress tears us apart 2Why bioethics literacy matters 2Why bioethics literacy matters 3
... Now, researchers at Yonsei University in Seoul, Republic of ... a layer of silver ions that can prevent growth ... Salmonella typhimurium and Campylobacter jejuni . The ... be particularly useful for applications in disaster recovery and ...
... is killing fishers in the southern Sierra Nevada, according ... scientists from the U.S. Forest Service,s Pacific Southwest Research ... Berkeley, and the Integral Ecology Research Center. ... team documented that rodenticides were being found in the ...
... 27, 2013 /PRNewswire-iReach/ -- Industry leader in healthcare ... to improve the family waiting room experience.  While ... the company now offers a customizable multilingual whiteboard ... preference.  Over 3o languages are currently available, with ...
Cached Biology News:Spinning up antibacterial silver on glass 2Illegal marijuana grows threaten fishers in the southern Sierra Nevada 2PatientStream announces the industry's first Multilingual family waiting room board 2PatientStream announces the industry's first Multilingual family waiting room board 3
Mouse HAI-1 Ectodomain MAb (Clone 199732)...
... Recognizes K+ Cl- Cotransporter-1 ... no significant sequence homology ... CCC.,SPECIES REACTIVITIES: The immunogen ... in human, mouse, porcine ...
IEX-1 S/L (H-20)...
Mouse monoclonal [1.T.4] to WAVE 1 ( Abpromise for all tested applications). Antigen: His6 fusion protein corresponding to full-length rat WAVE1. Entrez Gene ID: 8936...
Biology Products: